Summary
The optimal upper age limit in mammographic screening for breast cancer is still a matter for debate. The incidence of breast cancer rises gradually with increasing age and, without screening, breast cancer in elderly women is diagnosed at a more advanced stage than in younger women. After menopause, much of the glandular tissue of the breast is replaced by fat, which facilitates the mammographic detection of breast cancer in older women. Furthermore, the tumour growth rate decreases with increasing age.
Recently, a reduction in breast cancer mortality due to mammographic screening has been shown for women aged up to 75 years. There is a lack of data for women over the age of 75 years, however, because the number of women screened in the only study that included this age category is too small to give reliable results. We conclude that mammographic screening is beneficial at least up to the age of 75 years, and may also be beneficial up to age 85 years in healthy women with a good life expectancy.
Similar content being viewed by others
References
Van Dijck JAAM, Verbeek ALM, Hendriks JHCL, et al. Screening for breast cancer after the age of 70 years: a further reduction in breast cancer mortality? A review of the literature [in Dutch]. Ned Tijdschr Geneeskd 1995; 139: 428–33
Harris JR, Lippman ME, Veronesi U, et al. Breast cancer (first of three parts). N Engl J Med 1992; 327: 319–28
Campbell MK, Feuer EJ, Wun LM. Cohort-specific risks of developing breast cancer to age 85 in Connecticut. Epidemiology 1994; 5: 290–6
Parkin DM, Muir CS, Whelan SL, et al., editors. Cancer incidence in five continents. Vol. VI. Lyon: IARC Scientific Publications (No. 120), 1992
Hurley SF, Kaldor JM. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 1992; 14: 101–30
Fletcher SW, Black W, Harris R, et al. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993; 85: 1644–56
De Koning HJ, Boer R, Warmerdam PG, et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 1995; 87: 1217–23
Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. JAMA 1995; 273: 149–53
Miller AB. Mammography screening guidelines for women 40 to 49 and over 65 years old. Ann Epidemiol 1994; 4: 96–101
Leitch MA. Controversies in breast cancer screening. Cancer 1995; 76: 2064–9
Shapiro S. Periodic breast cancer screening in seven foreign countries. Cancer 1992; 69: 1919–24
Costanza ME. Breast cancer screening in older women: overview. J Gerontol 1992; 47: 1–3
Forum on breast cancer screening in older women. Screening recommendations of the forum panel. J Gerontol 1992; 47: 5
Hankey BF, Miller B, Curtis R, et al. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 1994; 16: 7–14
Feuer EJ, Wun L-M. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 1992; 136: 1423–36
Woolf SH. United States Preventive Services Task Force recommendations on breast cancer screening. Cancer 1992; 69: 1913–8
Peer PGM, Holland R, Hendriks JHCL, et al. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness. J Natl Cancer Inst 1994; 86: 436–41
Otten JDM, Van Dijck JAAM, Peer PGM, et al. Long-term breast cancer screening in Nijmegen: the 9 rounds from 1975–1992. J Epidemiol Comm Health 1996; 50: 353–8
Van Dijck JAAM, Verbeek ALM, Hendriks JHCL, et al. Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme. Br J Cancer. In press
Wegman ME. Annual summary of vital statistics: 1993. Pediatrics 1993; 92: 743–54
Kopans DB. Screening mammography in women over age 65. J Gerontol 1992; 47: 59–62
Clark GM, Osborne CK, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 1984; 2: 1102–9
Clark GM. The biology of breast cancer in older women. J Gerontol 1992; 47: 19–23
Peer PGM, Van Dijck JAAM, Hendriks JHCL, et al. Age-dependent growth rate of primary breast cancer. Cancer 1993; 71: 3547–51
Peer PGM, Verbeek ALM, Straatman H, et al. Age-specific sensitivities of mammographic screening for breast cancer. Breast Cancer Res Treat 1996; 38: 153–60
Adami H-O, Malker B, Holmberg L, et al. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986; 315: 559–63
Yancik R, Ries LG, Yates JW. Breast cancer in aging women: a population-based study of contrasts in stage, surgery, and survival. Cancer 1989; 63: 976–81
Bergman L, Kluck HM, Van Leeuwen FE, et al. The influence of age on treatment choice and survival of elderly breast cancer patients in South-Eastern Netherlands: a population-based study. Eur J Cancer 1992; 28A: 1475–80
Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer survival. Ann Intern Med 1994; 120: 104–10
Goodwin JS, Hunt WC, Samet JM. Determinants of cancer therapy in elderly patients. Cancer 1993; 72: 594–601
Silliman RA, Balducci L, Goodwin JS, et al. Breast cancer care in old age: what we know, don’t know, and do. J Natl Cancer Inst 1993; 85: 190–9
Balducci L. Perspectives on quality of life of older patients with cancer. Drugs Aging 1994; 4: 313–24
Bergman L, Van Dongen JA, Van Ooijen B, et al. Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease? Breast Cancer Res Treat 1995; 34: 77–83
Maher M, Dreyfus H, Campana F, et al. Management of breast cancer in the elderly. Eur J Cancer Care 1995; 4: 75–9
Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973–8
Day NE. Screening for breast cancer. Br Med Bull 1991; 47: 400–15
Morrison AS. Efficacy of screening for breast cancer in older women. J Gerontol 1992; 47: 80–4
Chen H-H, Tabár L, Fagerberg G, et al. Effect of breast cancer screening after age 65. J Med Screen 1995; 2: 10–4
Van Dijck JAAM, Holland R, Verbeek ALM, et al. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in the Netherlands. J Natl Cancer Inst 1994; 86: 934–8
Van Dijck JAAM, Verbeek ALM, Beex LVAM, et al. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. Int J Cancer 1996; 66: 727–31
Moss SM. Case-control studies of screening. Int J Epidemiol 1991; 20: 1–6
Morrison AS. Screening in chronic disease. 2nd ed. New York: Oxford University Press, 1992
Van Dijck JAAM, Verbeek ALM, Beex LVAM, et al. Breast cancer mortality in a non-randomised trial on mammographic screening in women over age 65. Int J Cancer. In press
Auvinen A, Elovainio L, Hakama M. Breast self-examination and survival from breast cancer. Breast Cancer Res Treat 1996; 38: 161–8
Mittra I. Breast screening: the case for physical examination without mammography. Lancet 1994; 343: 342–4
Miller AB, Baines CJ, Wall C. Canadian National Breast Screening Study, 2: breast cancer detection and death rates among women aged 50–59 years. Can Med Assoc J 1992; 147: 1477–88
Boyd NF, Jong RA, Yaffe MJ, et al. A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 1993; 189: 661–3
Koroltchouk V, Stanly K, Stjernswärd J. The control of breast cancer: a World Health Organization perspective. Cancer 1990; 65: 2803–10
Reintgen D, Berman C, Cox C, et al. The anatomy of missed breast cancers. Surg Oncol 1993; 2: 65–75
Scaf-Klomp W, Van Sonderen FL, Stewart R, et al. Compliance after 17 years of breast cancer screening. J Med Screen 1995; 2: 195–9
Costanza ME. The extent of breast cancer screening in older women. Cancer 1994; 74: 2046–50
Zapka JG, Berkowitz E. A qualitative study about breast cancer screening in older women: implications for research. J Gerontol 1992; 47: 43–9
McCool WF. Barriers to breast cancer screening in older women: a review. J Nurse Midwifery 1994; 39: 283–99
Blustein J. Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med 1995; 332: 1138–43
Mor V, Pacala JT, Rakowski W. Mammography for older women: who uses? Who benefits? J Gerontol 1992; 47: 43–9
Lidbrink E, Frisell J, Brandberg Y, et al. Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance. Breast Cancer Res Treat 1995; 35: 267–75
Boer R, de Koning HJ, van Oortmarssen GJ, et al. In search of the best upper age limit for breast cancer screening. Eur J Cancer 1995; 31A: 2040–3
Mandelblatt JS, Wheat ME, Monane M, et al. Breast cancer screening for elderly women with and without comorbid conditions. Ann Intern Med 1992; 116: 722–30
Kattlove H, Liberati A, Keeler E, et al. Benefits and costs of screening and treatment for early breast cancer. J Am Med Assoc 1995; 273: 142–8
De Koning HJ, Van Ineveld BM, Van Oortmarssen GJ, et al. Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991; 49: 531–7
Van Ineveld BM, Van Oortmarssen GJ, De Koning HJ, et al. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 1993; 29A: 1663–8
Carter R, Glasziou P, Van Oortmarssen G, et al. Cost-effectiveness of mammographic screening in Australia. Aust J Public Health 1993; 17: 42–50
Author information
Authors and Affiliations
Corresponding author
Additional information
This text is an update of an article previously published in the Dutch language.
Rights and permissions
About this article
Cite this article
van Dijck, J.A.A.M., Broeders, M.J.M. & Verbeek, A.L.M. Mammographic Screening in Older Women. Drugs & Aging 10, 69–79 (1997). https://doi.org/10.2165/00002512-199710020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199710020-00001